These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11280614)

  • 1. The smad proteins and TGFbeta signalling: uncovering a pathway critical in cancer.
    Rooke HM; Crosier KE
    Pathology; 2001 Feb; 33(1):73-84. PubMed ID: 11280614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular dynamics of Smad-mediated TGFbeta signaling.
    Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
    J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TGFbeta in human cancers.
    Wong SF; Lai LC
    Pathology; 2001 Feb; 33(1):85-92. PubMed ID: 11280615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
    Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
    Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation.
    Izzi L; Attisano L
    Oncogene; 2004 Mar; 23(11):2071-8. PubMed ID: 15021894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
    Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
    J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ; Tsang D; Brown TN; Crowe DL
    Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Smad nucleocytoplasmic shuttling in living cells.
    Nicolás FJ; De Bosscher K; Schmierer B; Hill CS
    J Cell Sci; 2004 Aug; 117(Pt 18):4113-25. PubMed ID: 15280432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD; Nachtigal MW
    Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
    Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
    Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
    Warner DR; Greene RM; Pisano MM
    FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
    Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
    J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
    Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
    Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.